• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Healthcare·7713.TWO
Share

WeLeader Biomedical Co., Ltd. Stocks

NT$ 73Last Updated 19.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

NT$ 102.39M

NT$ 73
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

WeLeader Biomedical Co. Ltd. is primarily involved in the development and distribution of medical diagnostic instruments and related supplies. The company offers specialized products such as integrated systems for serum biochemistry, alongside comprehensive solutions for clinical care and the management of medical information. Established on April 28, 2003, its principal operations are based in Kaohsiung City, Taiwan.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 11:24

The AI market is "almost certainly" in a bubble — billionaire Ken Griffin

21.10.2026 10:45

Netflix issued a weak forecast and scaled back its advertising plans. What is Wall Street saying?

21.10.2026 10:24

Top Stories This Morning: Anthropic Is Preparing for $750 Billion in Expenses; Musk Plans a Merger Between SpaceX and Tesla

21.10.2026 09:00

A Forgotten Sector with AI Potential: How the Citrini Experiment Became an Investment Opportunity

21.10.2026 08:00

JPMorgan has issued its first long-term forecast for Bitcoin. It could outperform stocks and gold

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026